Allergy Therapeutics (AGY)


Latest News

Allergy Therapeutics gets approval for PQ Grass trial

Allergy Therapeutics has received approval for a phase II clinical trial of investigating the dosing of PQ Grass, an ultra-sho...

Approval for PQ Grass Phase II trial

RNS Number: 9660Q Allergy Therapeutics PLC 18 September 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Approval of clinical trial application for PQ Grass Phase II trial - Trial aimed at determining optimal dose of an MPL-adjuvanted, modified grass allergy vaccine - 18 September 2017 Allergy Therapeutics plc (AIM:AGY), the fully integra...

Allergy Therapeutics expands R&D and clinical team

Allergy Therapeutics has announced new senior appointments and expansion of the R&D and clinical team in line with th...

Expansion of Clinical Development and R&D teams

RNS Number: 2846Q Allergy Therapeutics PLC 11 September 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Expansion of Clinical Development and R&D teams - Key appointments reflect Group's commitment to EU and US strategy for product development - 11 September 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated special...

All News

31-05-12Holding(s) in CompanyRNS
23-05-12Voluntary recall of Anapen by Lincoln MedicalRNS
17-05-12Holding(s) in CompanyRNS
17-05-12Holding(s) in CompanyRNS
16-05-12Total Voting RightsRNS
02-05-12Board AppointmentRNS
24-04-12Holding(s) in CompanyRNS
20-04-12Concert Party ShareholdingRNS
20-04-12Director/PDMR ShareholdingRNS
19-04-12Result of AGMRNS
18-04-12Markets: FTSE 100 uncertain on WednesdayInteractive Investor
18-04-12Result of OfferRNS
30-03-12Grant of OptionsRNS
30-03-12Fundraising AnnouncementRNS
30-03-12Half Yearly ReportRNS
14-03-12Notice of results and shareholder updateRNS
21-02-12Holding(s) in CompanyRNS
21-02-12Holding(s) in CompanyRNS
06-12-11Markets: FTSE 100 flat on TuesdayInteractive Investor
08-06-11Regulatory UpdateRNS
28-04-11Total Voting RightsRNS
26-04-11Markets: Manufacturing data lifts FTSE 100Interactive Investor
26-04-11FDA approval lifts shares in Allergy TherapeuticsInteractive Investor
26-04-11FDA UpdateRNS
20-04-11Exercise of OptionsRNS
11-04-11Holding(s) in CompanyRNS
11-04-11Holding(s) in CompanyRNS
07-04-11Grass MATA MPL dossier submitted in SwitzerlandRNS
06-04-11Allergic rhinitis vaccination website launchedRNS
30-03-11Director/PDMR ShareholdingRNS
29-03-11Director/PDMR ShareholdingRNS
29-03-11Director/PDMR ShareholdingRNS
28-03-11Markets: FTSE 100 trims gains on MondayInteractive Investor
28-03-11U.S. regulatory updateRNS
28-03-11Half Yearly ReportRNS
09-02-11Holding(s) in CompanyRNS
09-02-11Holding(s) in CompanyRNS
01-12-10Ten further MAAs submitted inRNS
18-11-10Result of AGMRNS
20-10-10Annual Financial ReportRNS

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory